Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are scheduled to have breast surgery, which may include full breast removal (mastectomy), modified radical mastectomy, or breast-conserving surgery, along with a lymph node biopsy, with or without removal of lymph nodes from the underarm area.
Who may not be able to join:
- People who have an active skin infection at or near the surgery site.
- People who have a blood clotting disorder or condition that affects how their blood clots.
- People who have had an allergic reaction to local anaesthetics (numbing medications) in the past.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Manoj K Karmakar, MD, Chinese University of Hong Kong
Phone: 3505 6157
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients requiring intraoperative ketamine
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.